The Food and Drug Administration (FDA) has approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a serious breathing disorder that affects millions. This marks the first medication specifically designed for certain patients with this condition, offering new hope for those struggling with it.
Source: https://www.washingtonpost.com/health/2024/12/20/fda-approves-zepbound-sleep-apnea